Nanosonics Limited (OTCMKTS:NNCSF – Get Free Report)’s stock price rose 28.1% during mid-day trading on Wednesday . The company traded as high as $2.8050 and last traded at $2.8050. Approximately 750 shares changed hands during trading, a decline of 35% from the average daily volume of 1,150 shares. The stock had previously closed at $2.19.
Wall Street Analysts Forecast Growth
Separately, Royal Bank Of Canada raised shares of Nanosonics from an “underperform” rating to a “sector perform” rating in a research note on Monday, January 19th. One equities research analyst has rated the stock with a Hold rating, According to data from MarketBeat, Nanosonics has an average rating of “Hold”.
Get Our Latest Research Report on NNCSF
Nanosonics Stock Performance
About Nanosonics
Nanosonics Limited is an Australia‐based medical technology company specializing in infection prevention solutions for the healthcare sector. Founded in 2001 and headquartered in Sydney, the company is best known for developing and commercializing its proprietary Trophon platform, which provides automated high‐level disinfection of ultrasound probes using sonically activated hydrogen peroxide vapor. Nanosonics holds numerous patents and regulatory approvals across multiple jurisdictions, positioning it as a leader in point‐of‐care decontamination.
The company’s flagship product, Trophon EPR, is designed to address the critical need for rapid, reliable disinfection of endocavity and surface ultrasound transducers.
Recommended Stories
Receive News & Ratings for Nanosonics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nanosonics and related companies with MarketBeat.com's FREE daily email newsletter.
